Divis Laboratories Ltd consolidated Q3FY22 PAT zooms to Rs. 902.24 crores

Divi's Laboratories Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 2509.86 crores during the period ended December 31, 2021 as compared to Rs. 2006.62 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 902.24 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 606.46 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 33.99 for the period ended December 31, 2021 as compared to Rs. 22.84 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 2509.86 crs	₹2006.62 crs	25.08%
Net Profit	₹902.24 crs	₹606.46 crs	48.77%
EPS	₹33.99	₹22.84	48.82%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 2509.86 crores during the period ended December 31, 2021 as compared to Rs.1720.76 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.902.24 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.470.62 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.33.99 for the period ended December 31, 2021 as compared to Rs.17.73 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 2509.86 crs	₹1720.76 crs	45.86%
Net Profit	₹902.24 crs	₹470.62 crs	91.71%
EPS	₹33.99	₹17.73	91.71%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.6502.87 crores during the 9 Months period ended December 31, 2021 as compared to Rs.5224.16 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.2065.81 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.1482.27 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.77.82 for the 9 Months period ended December 31, 2021 as compared to Rs.55.84 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹6502.87 crs	₹5224.16 crs	24.48%
Net Profit	₹2065.81 crs	₹1482.27 crs	39.37%
EPS	₹77.82	₹55.84	39.36%

Shares of Divi's Laboratories Limited was last trading in BSE at Rs. 4313.40 as compared to the previous close of Rs. 4330.75. The total number of shares traded during the day was 9418 in over 2139 trades.

The stock hit an intraday high of Rs. 4360.75 and intraday low of 4300.00. The net turnover during the day was Rs. 40729708.00.

Source : Equity Bulls

Keywords

DivisLaboratories Q3FY22 9MFY22 ResultUpdate